These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15738682)

  • 1. Comparison of three myofibroblast cell sources for the tissue engineering of cardiac valves.
    Hoffman-Kim D; Maish MS; Krueger PM; Lukoff H; Bert A; Hong T; Hopkins RA
    Tissue Eng; 2005; 11(1-2):288-301. PubMed ID: 15738682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning.
    Flanagan TC; Cornelissen C; Koch S; Tschoeke B; Sachweh JS; Schmitz-Rode T; Jockenhoevel S
    Biomaterials; 2007 Aug; 28(23):3388-97. PubMed ID: 17467792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tricuspid valve biopsy: a potential source of cardiac myofibroblast cells for tissue-engineered cardiac valves.
    Maish MS; Hoffman-Kim D; Krueger PM; Souza JM; Harper JJ; Hopkins RA
    J Heart Valve Dis; 2003 Mar; 12(2):264-9. PubMed ID: 12701801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of cell phenotype and extracellular matrix in tissue-engineered heart valves during in-vitro maturation and in-vivo remodeling.
    Rabkin E; Hoerstrup SP; Aikawa M; Mayer JE; Schoen FJ
    J Heart Valve Dis; 2002 May; 11(3):308-14; discussion 314. PubMed ID: 12056720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human cardiac valve interstitial cells in collagen sponge: a biological three-dimensional matrix for tissue engineering.
    Taylor PM; Allen SP; Dreger SA; Yacoub MH
    J Heart Valve Dis; 2002 May; 11(3):298-306; discussion 306-7. PubMed ID: 12056719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular smooth muscle cells as a valvular interstitial cell surrogate in heart valve tissue engineering.
    Appleton AJ; Appleton CT; Boughner DR; Rogers KA
    Tissue Eng Part A; 2009 Dec; 15(12):3889-97. PubMed ID: 19563261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and functional characterization of ovine cardiac valve-derived interstitial cells in primary isolates and cultures.
    Yperman J; De Visscher G; Holvoet P; Flameng W
    Tissue Eng; 2004; 10(9-10):1368-75. PubMed ID: 15588397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves.
    Rabkin-Aikawa E; Farber M; Aikawa M; Schoen FJ
    J Heart Valve Dis; 2004 Sep; 13(5):841-7. PubMed ID: 15473488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells.
    Sodian R; Lueders C; Kraemer L; Kuebler W; Shakibaei M; Reichart B; Daebritz S; Hetzer R
    Ann Thorac Surg; 2006 Jun; 81(6):2207-16. PubMed ID: 16731156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reference models for mitral valve tissue engineering based on valve cell phenotype and extracellular matrix analysis.
    Flanagan TC; Black A; O'Brien M; Smith TJ; Pandit AS
    Cells Tissues Organs; 2006; 183(1):12-23. PubMed ID: 16974091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue engineering of functional trileaflet heart valves from human marrow stromal cells.
    Hoerstrup SP; Kadner A; Melnitchouk S; Trojan A; Eid K; Tracy J; Sodian R; Visjager JF; Kolb SA; Grunenfelder J; Zund G; Turina MI
    Circulation; 2002 Sep; 106(12 Suppl 1):I143-50. PubMed ID: 12354724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation in tissue outcome of ovine and human engineered heart valve constructs: relevance for tissue engineering.
    van Geemen D; Driessen-Mol A; Grootzwagers LG; Soekhradj-Soechit RS; Riem Vis PW; Baaijens FP; Bouten CV
    Regen Med; 2012 Jan; 7(1):59-70. PubMed ID: 22168498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A xenogeneic acellularized matrix for heart valve tissue engineering: in vivo study in a sheep model].
    Leyh R; Wilhelmi M; Haverich A; Mertsching H
    Z Kardiol; 2003 Nov; 92(11):938-46. PubMed ID: 14634763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells.
    Schmidt D; Dijkman PE; Driessen-Mol A; Stenger R; Mariani C; Puolakka A; Rissanen M; Deichmann T; Odermatt B; Weber B; Emmert MY; Zund G; Baaijens FP; Hoerstrup SP
    J Am Coll Cardiol; 2010 Aug; 56(6):510-20. PubMed ID: 20670763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The independent role of cyclic flexure in the early in vitro development of an engineered heart valve tissue.
    Engelmayr GC; Rabkin E; Sutherland FW; Schoen FJ; Mayer JE; Sacks MS
    Biomaterials; 2005 Jan; 26(2):175-87. PubMed ID: 15207464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of cellular and extracellular matrix composition of native and tissue engineered heart valves.
    Schenke-Layland K; Riemann I; Opitz F; König K; Halbhuber KJ; Stock UA
    Matrix Biol; 2004 May; 23(2):113-25. PubMed ID: 15246110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Off-the-shelf human decellularized tissue-engineered heart valves in a non-human primate model.
    Weber B; Dijkman PE; Scherman J; Sanders B; Emmert MY; Grünenfelder J; Verbeek R; Bracher M; Black M; Franz T; Kortsmit J; Modregger P; Peter S; Stampanoni M; Robert J; Kehl D; van Doeselaar M; Schweiger M; Brokopp CE; Wälchli T; Falk V; Zilla P; Driessen-Mol A; Baaijens FP; Hoerstrup SP
    Biomaterials; 2013 Oct; 34(30):7269-80. PubMed ID: 23810254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue engineering of heart valves by recellularization of glutaraldehyde-fixed porcine valves using bone marrow-derived cells.
    Kim SS; Lim SH; Cho SW; Gwak SJ; Hong YS; Chang BC; Park MH; Song KW; Choi CY; Kim BS
    Exp Mol Med; 2006 Jun; 38(3):273-83. PubMed ID: 16819286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential cell sources for tissue engineering of heart valves in comparison with human pulmonary valve cells.
    Schaefermeier PK; Cabeza N; Besser JC; Lohse P; Daebritz SH; Schmitz C; Reichart B; Sodian R
    ASAIO J; 2009; 55(1):86-92. PubMed ID: 19092668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomechanical conditioning of tissue engineered heart valves: Too much of a good thing?
    Parvin Nejad S; Blaser MC; Santerre JP; Caldarone CA; Simmons CA
    Adv Drug Deliv Rev; 2016 Jan; 96():161-75. PubMed ID: 26555371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.